4.7 Review

Modular arrangements of sequence motifs determine the functional diversity of KDM proteins

Journal

BRIEFINGS IN BIOINFORMATICS
Volume 22, Issue 3, Pages -

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/bib/bbaa215

Keywords

histone methylation; KDM proteins; arrangements of sequence motifs; modular activities; evolution

Funding

  1. National Natural Science Foundation of China [61702290, 61861036]
  2. Program for Young Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region [NJYT-18-B01]
  3. Fund for Excellent Young Scholars of Inner Mongolia [2017JQ04]

Ask authors/readers for more resources

KDM proteins exhibit diverse biological functions through modular activities given by different sequence motifs, including catalytic, targeting, regulatory, and potential motifs. These motifs interact with each other to form a complex functional network.
Histone lysine demethylases (KDMs) play a vital role in regulating chromatin dynamics and transcription. KDM proteins are given modular activities by its sequence motifs with obvious roles division, which endow the complex and diverse functions. In our review, according to functional features, we classify sequence motifs into four classes: catalytic motifs, targeting motifs, regulatory motifs and potential motifs. JmjC, as the main catalytic motif, combines to Fe2+ and alpha-ketoglutarate by residues H-D/E-H and S-N-N/Y-K-N/Y-T/S. Targeting motifs make catalytic motifs recognize specific methylated lysines, such as PHD that helps KDM5 to demethylate H3K4me3. Regulatory motifs consist of a functional network. For example, NLS, Ser-rich, TPR and JmjN motifs regulate the nuclear localization. And interactions through the CW-type-C4H2C2-SWIRM are necessary to the demethylase activity of KDM1B. Additionally, many conservative domains that have potential functions but no deep exploration are reviewed for the first time. These conservative domains are usually amino acid-rich regions, which have great research value. The arrangements of four types of sequence motifs generate that KDM proteins diversify toward modular activities and biological functions. Finally, we draw a blueprint of functional mechanisms to discuss the modular activity of KDMs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Applied

The influence of high pressure processing and germination on anti-nutrients contents, in vitro amino acid release and mineral digestibility of soybeans

Xinyi Wu, Mei Tan, Yinfei Zhu, Hanying Duan, Hosahalli S. Ramaswamy, Weibin Bai, Chao Wang

Summary: The study found that high-pressure processing and germination can improve the protein digestibility and mineral bioavailability of soybeans, reduce the content of anti-nutrients, and contribute to the utilization of soybeans in the food industry.

JOURNAL OF FOOD COMPOSITION AND ANALYSIS (2023)

Article Pharmacology & Pharmacy

Scaling Pharmacodynamics from Rats to Humans to Support Erythropoietin and Romiplostim Combination Therapy to Treat Erythropoietin-Resistant Anemia

Xiaoqing Fan, Wojciech Krzyzanski, Dongyang Liu, Raymond S. M. Wong, Xiaoyu Yan

Summary: Recombinant human erythropoietin (rHuEPO) is an effective drug for anemia treatment in patients with chronic kidney disease. However, EPO-resistance is a significant issue. Combining rHuEPO with romiplostim, a thrombopoietin receptor agonist, can overcome EPO-resistance.

PHARMACEUTICS (2023)

Article Biochemical Research Methods

Development and validation of an HPLC coupled with tandem mass spectrometry method for the determination of HSK7653, a novel super long-acting dipeptidyl peptidase-4 inhibitor, in human plasma and urine and its application to a pharmacokinetic study

Yang Liu, Shuai Yan, Jie Liu, Hongzhong Liu, Ling Song, Xueting Yao, Ji Jiang, Fangqiong Li, Ke Du, Dongyang Liu, Pei Hu

Summary: In this article, a robust and sensitive HPLC coupled with tandem mass spectrometry method for determining the concentration of HSK7653 in human plasma and urine was developed and validated for the first time. The bioanalysis method has been fully validated and the results showed good sensitivity and specificity. Finally, this method was successfully applied to explore the pharmacokinetic characteristics of HSK7653 in Chinese healthy volunteers in a first-in-human study.

BIOMEDICAL CHROMATOGRAPHY (2023)

Article Pharmacology & Pharmacy

Model-informed drug development: The mechanistic HSK3486 physiologically based pharmacokinetic model informing dose decisions in clinical trials of specific populations

Miao Zhang, Zhiheng Yu, Huan Liu, Xu Wang, Haiyan Li, Xueting Yao, Dongyang Liu

Summary: HSK3486 is a central nervous system inhibitor that has demonstrated superior anesthetic properties compared to propofol. The high liver extraction ratio and limited susceptibility to rifampicin make HSK3486 suitable for a wide range of patients. However, in order to expand its indications, it is crucial to assess the systemic exposure of HSK3486 in specific populations and consider the gene polymorphism of UGT1A9, its main metabolic enzyme. A physiologically based pharmacokinetic model of HSK3486 was developed in 2019 to support model-informed drug development (MIDD) and predict the exposure in different populations. The predicted results showed slight increase in hepatic impairment and elderly patients, no change in severe renal impairment and neonates, and significant decrease in pediatric patients. The model also estimated increased exposure in the obese population and poor metabolizers of UGT1A9. Obesity and genetic polymorphisms are unlikely to result in clinically significant changes in anesthesia at the standard dose in adults.

BIOPHARMACEUTICS & DRUG DISPOSITION (2023)

Article Biochemistry & Molecular Biology

A cost-effective machine learning-based method for preeclampsia risk assessment and driver genes discovery

Hao Wang, Zhaoyue Zhang, Haicheng Li, Jinzhao Li, Hanshuang Li, Mingzhu Liu, Pengfei Liang, Qilemuge Xi, Yongqiang Xing, Lei Yang, Yongchun Zuo

Summary: This study developed a computational biology method using single-cell transcriptome to identify and predict pathological cell subpopulations of early-onset preeclampsia (PE). The TURF_XGB method achieved high accuracy and recall rates in classifying healthy placenta subpopulations, revealing the heterogeneity of placental biology. Additionally, the analysis revealed the involvement of dendritic cells and the role of C1QB and C1QC in mediating inflammation and driving the development of PE. The study also developed a risk stratification card for preeclampsia classification.

CELL AND BIOSCIENCE (2023)

Article Pharmacology & Pharmacy

Development of a PBPK model to quantitatively understand absorption and disposition mechanism and support future clinical trials for PB-201

Miao Zhang, Zihan Lei, Ziheng Yu, Xueting Yao, Haiyan Li, Min Xu, Dongyang Liu

Summary: PB-201 is the second glucokinase activator in the world to enter phase III clinical trials for the treatment of type 2 diabetes mellitus. With its efficacy advantages and favorable characteristics in absorption, distribution, metabolism, and excretion, PB-201 has a broad indication population. Estimating PB-201 exposure in specific populations is crucial to understand its pharmacokinetic characteristics and avoid hypoglycemia. The influence of internal and external factors on PB-201 exposure deserves attention for precision dosing and future clinical studies.

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2023)

Article Pharmacology & Pharmacy

A model-based meta analysis study of sodium glucose co-transporter-2 inhibitors

Xueting Yao, Jiawei Zhou, Ling Song, Yupeng Ren, Pei Hu, Dongyang Liu

Summary: Sodium-glucose co-transporter 2 (SGLT2) inhibitors, such as dapagliflozin, canagliflozin, and empagliflozin, show special benefits in reducing weight and heart failure risks for patients with type 2 diabetes mellitus (T2DM). A quantitative relationship between pharmacokinetics, pharmacodynamics, and disease end points (PK/PD/end points) was developed using data from clinical studies. A novel biomarker, the change of urine glucose excretion (UGE) from baseline normalized by fasting plasma glucose (delta UGE(c)), was identified to bridge healthy subjects and T2DM patients. This relationship offers insight into long-term efficacy prediction for SGLT2 inhibitors.

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2023)

Article Chemistry, Analytical

A method for quantification of human transporter proteins by liquid chromatography-tandem mass spectrometry

Zhe Hou, Lei Zhang, Xuan Guo, Hui Li, Xiaodong Li, Jing Dong, Guangqin Zhang, Dongyang Liu

Summary: The study developed a validated method using liquid chromatography-tandem mass spectrometry to quantify nine important transporter proteins in human tissues and organs. The method was validated for specificity, linearity, accuracy, precision, and stability. The results showed that the method is sensitive and efficient for quantification of the transporters.

SEPARATION SCIENCE PLUS (2023)

Article Pharmacology & Pharmacy

Model-Informed Dosing Regimen of Ticagrelor in Chinese Patients With Acute Coronary Syndrome

Yaxin Liu, Yun Kuang, Min Hai, Cheng Cui, Dongyang Liu, Guoping Yang

Summary: The exposure to ticagrelor is higher in East Asians, resulting in an increased risk of bleeding. A population pharmacokinetic model was developed and machine learning methods were used to construct bleeding risk models. The Random Forest model performed the best and a lower bleeding risk ticagrelor regimen can be obtained using this model.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

Article Pharmacology & Pharmacy

Dose decision of HSK7653 oral immediate release tablets in specific populations clinical trials based on mechanistic physiologically-based pharmacokinetic model

Miao Zhang, Shudong Zhang, Zhiheng Yu, Xueting Yao, Zihan Lei, Pangke Yan, Nan Wu, Xu Wang, Qin Hu, Dongyang Liu

Summary: HSK7653 is a candidate drug for the treatment of type 2 diabetes mellitus and its major elimination pathway is renal excretion. Evaluating the exposure of HSK7653 in patients with renal impairment and geriatric populations is important to bring more benefits to the patients. A PBPK model based on in vitro experimental results and in vivo renal clearance was developed to evaluate the effects of physiological factors and food on HSK7653 exposure.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

Article Multidisciplinary Sciences

Characterizing Cellular Differentiation Potency and Waddington Landscape via Energy Indicator

Hanshuang Li, Chunshen Long, Yan Hong, Liaofu Luo, Yongchun Zuo

Summary: This study quantitatively evaluated the differentiation potency of stem cells using the Hopfield neural network and found that it can be approximated by Hopfield energy values. The analysis of the energy landscape in embryogenesis and cell reprogramming processes revealed that cell fate decision is a continuous process. The study also deciphered the dynamics of the gene regulatory network involved in driving cell fate transition. These findings propose a new energy indicator for characterizing cellular differentiation potency and provide insights into the potential mechanism of cellular plasticity.

RESEARCH (2023)

Article Pharmacology & Pharmacy

Population Pharmacokinetic/Pharmacodynamic Analysis of the Glucokinase Activator PB201 in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus: Facilitating the Clinical Development of PB201 in China

Ling Song, Fangrui Cao, Shu Niu, Michael Xu, Ruifang Liang, Ke Ding, Zhigang Lin, Xueting Yao, Dongyang Liu

Summary: This study developed a population PK/PD model for PB201 and predicted its effects in a Chinese population with type 2 diabetes. The results showed that PB201 had persistent and dose-dependent glycemic effects and low risk of side effects.

CLINICAL PHARMACOKINETICS (2023)

Article Endocrinology & Metabolism

A model-informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong-acting dipeptidyl peptidase-4 inhibitor

Cheng Cui, Fangrui Cao, Iok Ian Kong, Qinghe Wu, Fangqiong Li, Haiyan Li, Dongyang Liu

Summary: This study aims to use a model-informed drug development approach to facilitate decision making and expedite the clinical progress of cofrogliptin for the treatment of type 2 diabetes. The study successfully achieved waiver approval for the phase 2b dose-finding study, paving the way for the clinical development of cofrogliptin and other DPP-4 inhibitors.

DIABETES OBESITY & METABOLISM (2023)

Article Infectious Diseases

Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study

Lin Gan, Xiaoxin Xie, Yanhua Fu, Xiaoyan Yang, Shujing Ma, Linghong Kong, Chunli Song, Yebing Song, Tingting Ren, Hai Long

Summary: This study evaluated the safety and efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) and Dolutegravir plus Lamivudine (DTG + 3TC) in a real-world setting and obtained the first dataset for switching to these regimens in a Chinese population. The results showed that both regimens were well tolerated and effective for switching HIV-1 infection therapy.

INFECTIOUS DISEASES AND THERAPY (2023)

Article Pharmacology & Pharmacy

Optimization of the dosage regimen of zoledronic acid with a kinetic-pharmacodynamic model and exposure-response analysis

Huan Wang, Qi Liu, Muhan Jiang, Chunli Song, Dongyang Liu

Summary: This study used a kinetic-pharmacodynamic model and exposure-response analysis to describe the changes in bone mineral density in different doses of zoledronic acid and established the relationship between dose and acute phase reaction.

FRONTIERS IN PHARMACOLOGY (2023)

No Data Available